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formulations (ie, Levopar capsules [Hexal], Levodopa comp. B 
STADA [STADApharm] and Levobens-Teva capsules [Teva]). Shape, 
color, appearance, and hardness (tablets) or surface, color, imprint, 
and content (capsules); mass (tablets) or fill-mass (capsules); content, 
degradation products, other unspecified impurities, disintegration 
time and dissolution after 30 minutes were assessed by standard phys-
ical and chemical laboratory tests along the original specifications.
Results: For all 7 generic products, at least 1 of the tested parameters 
fell outside the Madopar®/Prolopa® “shelf-life” specifications for 
the reference. Content requirements were unmet by 2 tablet formu-
lations for L-Dopa (specs: 100 mg ± 5%; test results: –5.6% and 
–7.6%) and for benserazide (specs: 28.5 mg ± 5%; –6.6% and 8.4%). 
Average mass (specs: 275 mg ±3%) was not reached for 2 tablet 
formulations (3.3%), and average fill mass (specs: 150 mg ±5%) was 
not reached for 3 capsule formulations (48.2%, 99.1%, 99.3%). The 
content of 1 capsule was brown (specs: light-beige). The quantity of 
2 benserazide degradation products (Ro 04-1419 and Ro 08-1 580; 
specs: max. 0.49%) was out of limits (0.62%) in 1 of the capsulated 
formulations.
Conclusion: All 7 analyzed generic L-Dopa/benserazide products 
exhibited at least 1 deviation compared with the shelf-life specifica-
tions of Madopar®/Prolopa®125. Deviations for the active ingredi-
ents ranged from 8.4% (benserazide) to –7.6% (L-Dopa) in 2 tablet 
products, which may result in clinical consequences for long-term 
administration. Furthermore, 2 of the degradation products were 
measured in excess of 26.5% above specification standards, posing a 
potential safety concern for treated patients. These results should lead 
to caution when prescribing a generic of Madopar®/Prolopa®, and 
also invite further investigations of a more comprehensive approach, 
from both pharmaceutical and clinical perspectives.
Disclosure of Interest: G. Vital-Durand: Employee of manufac-
turer. I. Arnet: None declared. U. Gasser: None declared. A. Fischer: 
Employee of manufacturer.
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Introduction: Although no clinically relevant resistance to the only 
schistosomicidal drug praziquantel (PZQ) has been described to date, 
development of drug resistance remains a growing threat. Calotropis 
(C.) procera, Ficus (F.) elastic, and Zingiber (Z.) officinale are well-
known medicinal plants and have been traditionally used for many 
diseases.The present work aimed to evaluate the antischistosomal 
activity of these plant extracts against Schistosoma (S.) mansoni.
Patients (or Materials) and Methods: Male mice exposed to 80 ±10 
cercariae/mouse were divided into 2 batches. The first was divided 
into 5 groups; (I) infected untreated, while groups from (II–V) were 
treated orally (500 mg/kg for 3 consecutive days) by aqueous stem 
latex and flowers of C procera, latex of F elastica and ether extract of 
Z officinale, respectively. The second batch was divided into 4 com-
parable groups (except Z officinale–treated group) similarly treated 
as the first batch in addition to the antacid ranitidine (30 mg/kg) 1 
hour before extract administration. Safety, worm recovery, tissues 
egg load, and oogram pattern were assessed.
Results: Results indicate that C procera latex and flower extracts 
are toxic even in small doses before washing off toxic rubber. 
Z officinale extract produced numerical insignificant decrease 
(7.26%) in S mansoni worms. When toxic rubber was washed off 
and the antacid ranitidine used, C procera (stem latex and flowers) 
and F elastica latex extracts revealed significant antischistosomal 
worm reductions by 45.31%, 53.7%, and 16.71%, respectively. 
Moreover, C procera extracts produced significant reductions in 
tissue egg load (≈ 34%–38.5%) and positively affect the oogram 
pattern.
Conclusion: The present study may be useful to supplement informa-
tion with regard to C procera and F elastica antischistosomal activity 
and provided a basis for subsequent experimental and clinical trials.
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Introduction: Dyes containing an azo (N = N) group are widely 
used in the food, pharmaceutical, cosmetic, and textile industries to 
provide color to products. Reports on the potential carcinogenicity 
of specific azo dyes, like Sudan I, has resulted in it being banned from 
use as a food additive. The association of the azo dyes, Tartrazine and 
Sunset Yellow, with the attention-deficit/ hyperactivity syndrome has 
further vilified azo dyes and focused scientific interest on its potential 
harmful effects. In an attempt to improve understanding of the azo 
dyes and in a search for new lead compounds for cancer drug devel-
opment, we have investigated the effects of a panel of 24 azo dyes on 
the survival of cancer cell lines.
Patients (or Materials) and Methods: A T-cell leukemic cell line 
(Jurkat) and a breast cancer cell line (MCF7) was maintained asepti-
cally in culture according to standard procedures. Cell were exposed 
to azo dyes, and their effects on cell growth and viability was deter-
mined by [3H]-thymidine incorporation into DNA. Labeled thymi-
dine incorporation into DNA was measured by precipitating DNA 
on glass fiber filtermats followed by liquid scintillation counting. Log 
dose-response curves were then constructed using the Graph-Pad 
Prizm software package.
Results: Four of the 20 compounds inhibited the proliferation of 
both Jurkat and MCF7 cells with IC50 values ranging between of 28 
and 82 micromoles. MCF7 cells were inhibited by Eriochrome Blue 
Black B and Eriochrome Black T with IC50 values of 28.43 (1.13) 
and 37.22 (4.6) µM, respectively. Jurkat cells were most sensitive to 
Eriochrome Black T with an IC50 value of 38.69 (2.26) µm compared 
with Eriochrome Blue Black with an IC50 value of 79.95 (1.01). 
Furthermore, Palatine Chrome Black 6BN and 4-phenylazophenol 
inhibited Jurkat cells with IC50 values of 82.04 (1.02) and 72.61 
(1.03) µM, respectively. These data support previous reports regard-
ing the anticancer properties of Eriochrome Black T.
Conclusion: This preliminary study identified 4 azo dyes whose 
structures can serve as lead compounds for new cancer drug devel-
opment. Further studies will investigate the effects of azo dyes on cell 
lines derived from other cancers and determine the potential of the 
active dyes to induce apoptosis.
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